Reviewing Evolus (NASDAQ:EOLS) & Green Hygienics (OTCMKTS:GRYN)

Evolus (NASDAQ:EOLSGet Free Report) and Green Hygienics (OTCMKTS:GRYNGet Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.

Valuation & Earnings

This table compares Evolus and Green Hygienics’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Evolus $184.73 million 3.03 -$74.41 million ($1.11) -8.81
Green Hygienics N/A N/A N/A ($0.25) 0.00

Green Hygienics has lower revenue, but higher earnings than Evolus. Evolus is trading at a lower price-to-earnings ratio than Green Hygienics, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

65.2% of Evolus shares are owned by institutional investors. Comparatively, 0.3% of Green Hygienics shares are owned by institutional investors. 5.4% of Evolus shares are owned by insiders. Comparatively, 0.3% of Green Hygienics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Evolus and Green Hygienics, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolus 0 0 4 0 3.00
Green Hygienics 0 0 0 0 N/A

Evolus presently has a consensus target price of $21.40, suggesting a potential upside of 121.30%. Given Evolus’ higher possible upside, research analysts clearly believe Evolus is more favorable than Green Hygienics.


This table compares Evolus and Green Hygienics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Evolus -34.11% -507.42% -32.41%
Green Hygienics N/A N/A N/A

About Evolus

(Get Free Report)

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

About Green Hygienics

(Get Free Report)

Green Hygienics Holdings, Inc., a development stage company, focuses on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol. The company was formerly known as Takedown Entertainment Inc. and changed its name to Green Hygienics Holdings Inc. in July 2012. Green Hygienics Holdings, Inc. was incorporated in 2008 and is headquartered in Poway, California. On July 11, 2023, Green Hygienics Holdings Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

Receive News & Ratings for Evolus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolus and related companies with's FREE daily email newsletter.